{"id":5618,"date":"2017-12-29T06:38:12","date_gmt":"2017-12-29T06:38:12","guid":{"rendered":"https:\/\/www.quancapital.com\/?page_id=5618"},"modified":"2020-07-23T04:36:50","modified_gmt":"2020-07-23T04:36:50","slug":"portfolio","status":"publish","type":"page","link":"https:\/\/cn.quancapital.com\/en\/portfolio\/","title":{"rendered":"Portfolio"},"content":{"rendered":"

[vc_row content_width=”grid” content_aligment=”center” css=”.vc_custom_1519907228931{padding-top: 80px !important;padding-bottom: 50px !important;}”][vc_column]

\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tAdcentrx\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tAdicet\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech discovering and developing allogeneic gamma delta T cell therapies<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tAlebund\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Late clinical-stage Biopharmaceutical company discovering and developing therapies for the treatment of renal diseases and related chronic conditions<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tARCELLX\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech focusing on developing breakthrough CAR-T cell therapies<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tAvenzo\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tCentrexion\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Late clinical -stage biotech with one of the largest pipelines of novel, non-opioid therapies for chronic pain management<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tCrescendo Biologics\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> UK clinical-stage biotech developing potent, multi-functional Humabody therapeutics<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tDesign Therapeutics\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical stage biotechnology company developing breakthrough therapies based on GeneTAC\u2122 platform to address diseases caused by genetic expansion<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tEluminex\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotechnology company focusing on innovative therapeutics in ophthalmic diseases<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tiCarbonX\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Leading Chinese technology platform focusing on life science<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tIntelligem\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Biotech company specializing in non-absorbable drugs for metabolic diseases<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tKira Pharmaceuticals\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech discovering breakthrough therapies for complement-mediated diseases<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tMEDx Translational Medicine Co., Ltd.\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Precision medicine leader in China offering integrated solutions of biomarkers, companion diagnostics and clinical testing<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tNextCure\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tOricell\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Leading China biotech of cell therapy with breakthrough in solid tumor<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tPinnacle\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Biotechnology company focused on developing first-in-class oral peptide pipeline against validated biologic targets with large unmet needs<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tRarestone Group\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Late clinical-stage biotech with an integrated platform for the development and commercialization of rare disease medicines in China<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tSail Biomedicines\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Harnesses the power of first-in-category programmable payloads of eRNA, nanoparticles, and emerging, proprietary AI technologies, to unlock the comprehensive programming of medicines<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tSilexon\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Emerging AI-empowered technology company in China, leveraging unique algorithms to facilitate data-driven life science research<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tSyros\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> First-in-class clinical pipeline targeting gene control in oncology<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tTempest\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech focusing on Immune-related pathways in oncology<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tTherorna\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Leading Chinese biotech focusing on next-generation RNA technology with global potential in multiple disease areas<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tWindward Bio\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tZenas BioPharma\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Clinical-stage biotech developing immune-based therapies for the world<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tZidan\t\t\t\t<\/h5>\t\n\t\t\t\t
All not exited<\/span> \/<\/span> Innovative minimal invasive medtech for early-stage lung cancer treatment<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n
<\/div>\n
<\/div>\n
<\/div>\n
<\/div>\n<\/div><\/div>[\/vc_column][\/vc_row][vc_row content_width=”grid” content_aligment=”center” css=”.vc_custom_1519907228931{padding-top: 80px !important;padding-bottom: 50px !important;}”][vc_column][vc_text_separator title=”Exited” title_align=”separator_align_left” align=”align_left”][vc_empty_space height=”25px”]
\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tARMO Biosciences\t\t\t\t<\/h5>\t\n\t\t\t\t
All exited<\/span> \/<\/span> Late clinical-stage immuno-oncology biotech with novel, proprietary pipeline<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tdMed\t\t\t\t<\/h5>\t\n\t\t\t\t
All exited<\/span> \/<\/span> Leading Chinese specialty clinical development CRO that serves local and global biotech\/pharma clients<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n\n
\n\t<\/a>\n\t
\n\t
<\/div>\t\n\t\"\"\t\t\t\t\n\t<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t\tInterius\t\t\t\t<\/h5>\t\n\t\t\t\t
All exited<\/span> \/<\/span> Preclinical stage biotech company developing a paradigm-shifting platform for cell-specific in vivo gene delivery<\/span><\/div>\t\t\t<\/div>\n\t\t<\/div>\t\n\t<\/div>\n<\/article>\n\n
<\/div>\n
<\/div>\n
<\/div>\n
<\/div>\n<\/div><\/div>[\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row content_width=”grid” content_aligment=”center” css=”.vc_custom_1519907228931{padding-top: 80px !important;padding-bottom: 50px !important;}”][vc_column][\/vc_column][\/vc_row][vc_row content_width=”grid” content_aligment=”center” css=”.vc_custom_1519907228931{padding-top: 80px !important;padding-bottom: 50px !important;}”][vc_column][vc_text_separator title=”Exited” title_align=”separator_align_left” align=”align_left”][vc_empty_space height=”25px”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5618"}],"collection":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/comments?post=5618"}],"version-history":[{"count":8,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5618\/revisions"}],"predecessor-version":[{"id":6876,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5618\/revisions\/6876"}],"wp:attachment":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/media?parent=5618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}